These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7903288)

  • 41. Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index.
    Gorgoulis V; Zoumpourlis V; Rassidakis G; Karameris A; Barbatis C; Spandidos DA; Kittas C
    Virchows Arch; 1995; 426(4):339-44. PubMed ID: 7599785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. P53 and PCNA is positively correlated with HPV infection in laryngeal epitheliopapillomatous lesions in patiets with different ethnic backgrounds in Xinjiang.
    Sun J; Xiong J; Zhen Y; Chen ZL; Zhang H
    Asian Pac J Cancer Prev; 2012; 13(11):5439-44. PubMed ID: 23317197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alteration of p53 gene structure and function in laryngeal squamous cell cancer.
    Golusinski W; Olofsson J; Szmeja Z; Szyfter K; Szyfter W; Biczysko W; Hemminki K
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S133-7. PubMed ID: 9065648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p53, PCNA and Ki67 in laryngeal cancer.
    Golusiński W; Olofsson J; Szmeja Z; Majewski P
    Pol J Pathol; 1996; 47(4):175-82. PubMed ID: 9097709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus.
    Kimura H; Konishi K; Maeda K; Yabushita K; Kuroda Y; Tsuji M; Miwa A
    Hepatogastroenterology; 1999; 46(25):285-9. PubMed ID: 10228808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
    Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
    Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.
    Visakorpi T; Kallioniemi OP; Heikkinen A; Koivula T; Isola J
    J Natl Cancer Inst; 1992 Jun; 84(11):883-7. PubMed ID: 1350643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.
    Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szkudlarek T; Jeleń-Krzeszewska J
    Oral Oncol; 1999 Mar; 35(2):180-6. PubMed ID: 10435153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
    Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
    J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
    Ogura K; Fukuzawa S; Habuchi T; Ogawa O; Yoshida O
    Int J Urol; 1997 Nov; 4(6):561-6. PubMed ID: 9477184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Assessment of usefulness of PCNA and protein p53 in subjects with laryngeal cancer with local recurrence].
    Morawski K; Gabriel A; Namysłowski G; Pietrawska V; Ziółkowski A; Urbaniec P
    Otolaryngol Pol; 2000; 54 Suppl 31():174-7. PubMed ID: 10974877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparative study of HPV infection and proliferating cell nuclear antigen of uterine cervix].
    Murakami T; Nagai N; Ota S; Ohama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):967-72. PubMed ID: 8103785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications.
    Dolcetti R; Doglioni C; Maestro R; Gasparotto D; Barzan L; Pastore A; Romanelli M; Boiocchi M
    Int J Cancer; 1992 Sep; 52(2):178-82. PubMed ID: 1521906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Qualitative and quantitative parameters for prognosis in renal carcinoma in early and advanced stages].
    Del Vecchio MT; Spina D; Lazzi S; Bruni A; Funtò I; Mattei FM; Fornaini M; Luzi P; Tosi P
    Pathologica; 1997 Aug; 89(4):390-6. PubMed ID: 9471607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of PCNA and mutant p53 expression in laryngeal squamous cell carcinoma.
    Buyukbayram H; Cureoglu S; Arslan A; Işikakdogan AR
    Cancer Invest; 2004; 22(2):195-202. PubMed ID: 15199601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
    Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
    Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis.
    de Rosa I; Staibano S; Lo Muzio L; Delfino M; Lucariello A; Coppola A; De Rosa G; Scully C
    J Oral Pathol Med; 1999 Jul; 28(6):252-8. PubMed ID: 10426197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The significance of PCNA and p53 protein in some oral tumors.
    Tsuji T; Mimura Y; Wen S; Li X; Kanekawa A; Sasaki K; Shinozaki F
    Int J Oral Maxillofac Surg; 1995 Jun; 24(3):221-5. PubMed ID: 7594756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S; Nakano H; Tsuneyoshi M
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.